首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3206797篇
  免费   245783篇
  国内免费   8143篇
耳鼻咽喉   43681篇
儿科学   104396篇
妇产科学   87181篇
基础医学   461552篇
口腔科学   89409篇
临床医学   292032篇
内科学   627633篇
皮肤病学   73380篇
神经病学   257249篇
特种医学   124018篇
外国民族医学   743篇
外科学   487768篇
综合类   70513篇
现状与发展   14篇
一般理论   1168篇
预防医学   256458篇
眼科学   73315篇
药学   235211篇
  13篇
中国医学   5969篇
肿瘤学   169020篇
  2018年   35046篇
  2017年   26736篇
  2016年   30741篇
  2015年   34571篇
  2014年   48667篇
  2013年   73527篇
  2012年   97249篇
  2011年   103934篇
  2010年   62877篇
  2009年   60047篇
  2008年   97276篇
  2007年   103793篇
  2006年   105164篇
  2005年   102010篇
  2004年   97332篇
  2003年   94195篇
  2002年   90882篇
  2001年   146413篇
  2000年   150265篇
  1999年   126692篇
  1998年   38035篇
  1997年   33517篇
  1996年   34244篇
  1995年   33250篇
  1994年   30743篇
  1993年   28937篇
  1992年   100965篇
  1991年   98528篇
  1990年   95842篇
  1989年   92025篇
  1988年   84925篇
  1987年   83380篇
  1986年   78508篇
  1985年   75500篇
  1984年   56889篇
  1983年   48326篇
  1982年   29343篇
  1981年   26399篇
  1979年   52082篇
  1978年   37450篇
  1977年   31221篇
  1976年   29586篇
  1975年   31542篇
  1974年   37668篇
  1973年   35857篇
  1972年   33742篇
  1971年   31616篇
  1970年   28969篇
  1969年   27587篇
  1968年   25431篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass.  相似文献   
12.
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19.  相似文献   
13.
14.
15.
16.
Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients presenting with these symptoms. More importantly, patients being monitored for smoldering multiple myeloma and a monoclonal gammopathy of undetermined significance (MGUS) are at risk for developing AL amyloidosis. MGUS and myeloma patients that have atypical features, including unexplained weight loss; lower extremity edema, early satiety, and dyspnea on exertion should be considered at risk for light chain amyloidosis. Overlooking the diagnosis of light chain amyloidosis leading to therapy delay is common, and it represents an error of diagnostic consideration. Herein we provide a review of established and investigational treatments for patients with AL amyloidosis and provide algorithms for workup and management of these patients.Subject terms: Myeloma, Chemotherapy  相似文献   
17.
18.
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this review by highlighting the diversity of FGFR genomic alterations identified in human cancers and the current challenges associated with the development of clinical-grade molecular diagnostic tests to accurately detect these alterations in the tissue and blood of patients. The past decade has seen significant advancements in the development of FGFR-targeted therapies, which include selective, non-selective and covalent small-molecule inhibitors, as well as monoclonal antibodies against the receptors. We describe the expanding landscape of anti-FGFR therapies that are being assessed in early phase and randomised controlled clinical trials, such as erdafitinib and pemigatinib, which are approved by the Food and Drug Administration for the treatment of FGFR3-mutated urothelial carcinoma and FGFR2-fusion cholangiocarcinoma, respectively. However, despite initial sensitivity to FGFR inhibition, acquired drug resistance leading to cancer progression develops in most patients. This phenomenon underscores the need to clearly delineate tumour-intrinsic and tumour-extrinsic mechanisms of resistance to facilitate the development of second-generation FGFR inhibitors and novel treatment strategies beyond progression on targeted therapy.Subject terms: Cancer, Cancer  相似文献   
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号